Prior Steroid | Prior Anti-VEGF | Prior Laser | ||||
---|---|---|---|---|---|---|
Endpoint | DEX 0.7 | Sham | DEX 0.7 | Sham | DEX 0.7 | Sham |
n = 58 | n = 61 | n = 25 | n = 26 | n = 231 | n = 243 | |
Patients with BCVA ≥15-letter improvement from baseline at study end, % | 27.6 | 8.2 | 28.0 | 7.7 | 21.2 | 11.9 |
Mean BCVA average change from baseline during the study (SD), lettersa | +4.9 (7.4) | −0.6 (8.6) | +4.2 (8.8) | +1.6 (7.6) | +3.1 (8.7) | +1.6 (7.5) |
Mean CRT average change from baseline during the study (SD), μma | −121 (150) | −30 (135) | −130 (95) | −42 (123) | −123 (130) | −39 (121) |